H. Gahéry-Ségard

发表

Differential chronology of TCRADV2 gene use by α and δ chains of the mouse TCR

P. Cazenave, S. Candéias, E. Jouvin-Marche, 1998 .

Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers

J. Levy, J. Guillet, S. Fournier, 2001, AIDS.

Peptide-Binding Specificity Molecule , Defines a New Supertype of HLA-DP 4 , the Most Frequent HLA II

H. Zarour, A. Ménez, B. Maillère, 2002 .

Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients.

T. Tursz, J. Guillet, F. Le Gal, 2000, Human gene therapy.

Immune Response to Recombinant Capsid Proteins of Adenovirus in Humans: Antifiber and Anti-Penton Base Antibodies Have a Synergistic Effect on Neutralizing Activity

T. Tursz, P. Boulanger, J. Guillet, 1998, Journal of Virology.

Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.

P. Opolon, L. Zitvogel, A. Cesne, 1997, The Journal of clinical investigation.

Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response

P. Boulanger, J. Guillet, Saw-See Hong, 2002, Journal of Virology.

Distinct Roles of Adenovirus Vector-Transduced Dendritic Cells, Myoblasts, and Endothelial Cells in Mediating an Immune Response against a Transgene Product

J. Guillet, M. Eloit, H. Gahéry-Ségard, 2002, Journal of Virology.

Humoral immune response to the capsid components of recombinant adenoviruses: Routes of immunization modulate virus‐induced Ig subclass shifts

A. Pavirani, J. Guillet, H. Gahéry-Ségard, 1997, European journal of immunology.

Differential chronology of TCRADV2 gene use by alpha and delta chains of the mouse TCR.

P. Cazenave, S. Candéias, P. Marche, 1998, European journal of immunology.

Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals

C. Rouzioux, M. Kazatchkine, Y. Lévy, 2006, AIDS.

HLA-DP4, the Most Frequent HLA II Molecule, Defines a New Supertype of Peptide-Binding Specificity1

Alain Sanson, H. Zarour, A. Ménez, 2002, The Journal of Immunology.

Germline genomic structure of the B10.A mouseTcra-V2 gene subfamily

B. Malissen, P. Cazenave, A. Six, 2007, Immunogenetics.

Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients

C. Rouzioux, Y. Lévy, J. Guillet, 2005, AIDS.

Long-Term Specific Immune Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine: Characterization of CD8+-T-Cell Epitopes Recognized

J. Levy, J. Guillet, G. Pialoux, 2003, Journal of Virology.

Lipopeptide‐based melanoma cancer vaccine induced a strong MART‐27‐35‐cytotoxic T lymphocyte response in a preclinal study

V. Engelhard, J. Guillet, A. Prévost-Blondel, 2002, International journal of cancer.

Multiepitopic B- and T-Cell Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine

J. Levy, J. Guillet, G. Pialoux, 2000, Journal of Virology.

Immune Response to Recombinant Adenovirus in Humans: Capsid Components from Viral Input Are Targets for Vector-Specific Cytotoxic T Lymphocytes

T. Tursz, M. Mehtali, P. Boulanger, 2000, Journal of Virology.

Evaluation of the Interlaboratory Concordance in Quantification of Human Immunodeficiency Virus-Specific T Cells with a Gamma Interferon Enzyme-Linked Immunospot Assay

A. Samri, B. Autran, E. Tartour, 2006, Clinical and Vaccine Immunology.

Use of well-defined HIV-derived epitopes to evaluate CD4(+) and CD8(+) T cell responses in patients with chronic HIV-1 infection treated with HAART.

W. Rozenbaum, S. Grabar, J. Guillet, 2004, AIDS research and human retroviruses.